Red light therapy for inflammation: how light modulates the inflammatory cascade

Inflammation is a cascade: injury or stress triggers cells to release pro-inflammatory signaling molecules (cytokines like IL-1β, IL-6, and TNF-α), which recruit immune cells, increase vascular permeability, and create the classic signs of inflammation — swelling, redness, heat, pain. This process is necessary for healing but becomes counterproductive when excessive or chronic.

Red and near-infrared light at the right wavelengths appear to modulate this cascade at multiple points. The primary mechanism starts in the mitochondria: photobiomodulation reduces mitochondrial oxidative stress, which is one of the upstream triggers for NF-κB — the master regulator of inflammatory gene expression. When mitochondrial reactive oxygen species are lowered, the inflammatory signaling they drive is also dampened.

Near-infrared vs red for deeper inflammation

For surface-level inflammatory conditions — skin redness, rosacea, wound inflammation — 630–660nm red light is appropriate because it penetrates the epidermis and upper dermis. For deeper inflammation in muscles, tendons, joints, or subdermal tissue, 810–850nm near-infrared is necessary because these wavelengths penetrate further into tissue without being absorbed at the surface.

Many clinical-grade full-body beds offer both wavelengths simultaneously. For joint pain, muscle inflammation, or inflammatory conditions that are clearly below the skin's surface, near-infrared alone or in combination is likely more effective.

Where evidence is strongest

• Musculoskeletal inflammation: joints, tendons, and muscles — the evidence base here is substantial, and RLT is used therapeutically in physical therapy and sports medicine settings.
• Post-exercise inflammation: similar mechanisms to muscle recovery, with reduced inflammatory markers after RLT application.
• Arthritis: several trials show reduced pain and inflammatory markers in both osteoarthritis and rheumatoid arthritis — though it's a complement, not a replacement, for disease management.
• Neuropathic inflammation: emerging evidence in nerve tissue inflammation; less established than musculoskeletal.
• Not established: inflammatory bowel disease, systemic autoimmune conditions — light doesn't penetrate the gut or deep enough for these applications.